G. Shaw

发表

Integrated clinical and basic studies related to circumventing non-small cell lung cancer drug resistance.

B. Kramer, J. Minna, A. Gazdar, 1994, Lung cancer.

Strategies for lung cancer chemoprevention

J. Mulshine, I. Avis, F. Cuttitta, 1993 .

Scientific basis for cancer prevention intermediate cancer markers

J. Mulshine, I. Avis, M. Jett, 1993, Cancer.

Candidate biomarkers for applications as intermediate end points of lung carcinogenesis

J. Mulshine, M. Birrer, I. Avis, 1992, Journal of cellular biochemistry. Supplement.

Genetic polymorphism of CYP2D6 and lung cancer risk.

M. Tucker, H. Pass, J. Nesbitt, 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Peptide amidating activity in human bronchoalveolar lavage fluid.

M. Tockman, J. Mulshine, K. Kelly, 1996, Lung cancer.

Primary and Secondary Prevention of Lung Cancer: an International Association for the Study of Lung Cancer workshop.

J. Mulshine, B. Johnson, J. Battey, 1995, Lung cancer.

Human debrisoquine hydroxylase gene polymorphisms in cancer patients and controls.

R. Hoover, C. Harris, J. Resau, 1990, Carcinogenesis.

Clinical implications of the competitive inhibition of the debrisoquin-metabolizing isozyme by quinidine.

N. Caporaso, G. Shaw, 1991, Archives of internal medicine.

The debrisoquine metabolic phenotype and DNA-based assays: implications of misclassification for the association of lung cancer and the debrisoquine metabolic phenotype.

R. Hoover, C. Harris, M. Tucker, 1992, Environmental health perspectives.

Lung tumor resection does not affect debrisoquine metabolism.

R. Hoover, H. Issaq, J. Nesbitt, 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Clinical experience with sorbinil--an aldose reductase inhibitor.

J. Collier, M. Peterson, G. Shaw, 1986, Metabolism: clinical and experimental.

Identification of a new variant CYP2D6 allele with a single base deletion in exon 3 and its association with the poor metabolizer phenotype.

M. Relling, D. Moir, M. Relling, 1994, Human molecular genetics.

Molecular Biology of Early Lung Carcinogenesis and Applications to Intermediate Markers

E. Szabo, G. Shaw, 2022 .

Initiators and promoters of lung cancer.

J. Mulshine, M. Birrer, A. Treston, 1993, Chest.

Frequency of the variant allele CYP2D6(C) among North American Caucasian lung cancer patients and controls.

H. Issaq, D. Moir, N. Caporaso, 1997, Lung cancer.

Debrisoquine metabolism and lung cancer risk.

R. Hoover, M. Tucker, H. Issaq, 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

The determination of debrisoquine and its 4-hydroxy metabolite in urine by capillary gas chromatography and high performance liquid chromatography

H. Issaq, N. Caporaso, R. Falk, 1993 .

Correlation of in vitro drug sensitivity testing results with response to chemotherapy and survival: Comparison of non‐small cell lung cancer and small cell lung cancer

S. Steinberg, J. Minna, A. Gazdar, 1996, Journal of cellular biochemistry. Supplement.

Individualized chemotherapy for patients with non-small cell lung cancer determined by prospective identification of neuroendocrine markers and in vitro drug sensitivity testing.

S. Steinberg, J. Minna, A. Gazdar, 1993, Cancer research.

Identification of pathologically insignificant prostate cancer is not accurate in unscreened men

S. Vowler, D. Neal, N. Shah, 2014, British Journal of Cancer.

Changing patterns of lung cancer incidence by histological type.

W. Blot, S. Devesa, G. Shaw, 1991, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Lung cancer risk associated with cancer in relatives.

T J Mason, P A Buffler, L. Pickle, 1991, Journal of clinical epidemiology.

Race and sex differences in associations of vegetables, fruits, and carotenoids with lung cancer risk in New Jersey (United States)

P. Hartge, R. Ziegler, J. Schoenberg, 1993, Cancer Causes & Control.

Monoclonal antibodies for early cytologic detection of lung cancer.

J. Mulshine, G. Shaw, 1993, Seminars in Thoracic and Cardiovascular Surgery.

Additional clues to lung cancer risk.

G. Shaw, 1999, Cancer investigation.

Age at onset for familial epithelial ovarian cancer

P. Hartge, C. Amos, M. Tucker, 1992, JAMA.